Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,744 | 0 | 0 | N/A | 0 |
| TOTAL | $7,483 | $0 | $0 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 1,741 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 2,759 | 0 | 0 | 0 | 0 |
| TOTAL | $4,500 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $11,983 | $0 | $0 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 305 | 0 | 0 | N/A | 0 |
| Accounts payable and accrued liabilities | 2,627 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 2,330 | 0 | 0 | N/A | 0 |
| TOTAL | $5,406 | $0 | $0 | $N/A | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | 211 | 0 | 0 | N/A | 0 |
| Other Non-Current Liabilities | 7,071 | 0 | 0 | 0 | 0 |
| TOTAL | $7,293 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $12,699 | $0 | $0 | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,542 | N/A | N/A | N/A | N/A |
| Retained earnings | -50,321 | 0 | 0 | N/A | 0 |
| Other shareholders' equity | 48,369 | 0 | 0 | 0 | 0 |
| TOTAL | $-716 | $0 | $0 | $N/A | $0 |
| Total Liabilities And Equity | $11,983 | $0 | $0 | $0 | $0 |